A multivariate Bayesian biomarker screening algorithm that incorporates clinical covariates.
Advanced hepatocellular carcinoma (HCC) has limited treatment options and poor survival. Early detection of HCC improves survival, but current ultrasound screening is inconsistent and poorly adhered to. Biomarker-based blood tests offer a more accurate, accessible, and reliable alternative. Recent developments in metho...